NCT02541409View on ClinicalTrials.gov

Directly Observed Therapy for HCV in Chennai, India

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Hepatitis C, Chronic
Interventions
DRUG

Sofosbuvir

Direct acting antiviral agent used for the treatment of hepatitis C

DRUG

Pegylated Interferon alfa-2a

Antiviral agent used for the treatment of hepatitis C

DRUG

Ribavirin

Antiviral agent (guanosine analogue) used for the treatment of hepatitis C

Trial Locations (1)

600113

YR Gaitonde Centre for AIDS Research and Education, Chennai

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

YR Gaitonde Centre for AIDS Research and Education

OTHER

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT02541409 - Directly Observed Therapy for HCV in Chennai, India | Biotech Hunter | Biotech Hunter